Epidemiology and Risk Factors for Injuries in Beach Tennis Players
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DE LA RÉUNION · Nov 19, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding injuries that occur among beach tennis players. Beach tennis is a popular sport that has grown a lot since it started in Italy in the 1970s, especially on La Réunion island since 2000. However, there isn't much research specifically looking at injuries related to this sport, and previous studies have had limitations. This trial aims to gather new information over one year to help identify the risk of injuries in beach tennis players and improve prevention and treatment strategies.
To be eligible to participate in this study, you should be at least 18 years old and play beach tennis regularly (at least once a week). It doesn't matter if you're a male or female, or if you belong to a club; you just need to be able to read and understand French and be willing to take part in the research. If you join the study, you can expect to share your experiences and any injuries you may have while playing beach tennis over the year. This information will be valuable for making the sport safer for everyone. Please note that people who are under guardianship or court protection cannot participate in this trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Player declaring that they train regularly in beach tennis (at least once a week)
- • At least 18 years old at the time of inclusion
- • Male or female
- • Able to read and understand French
- • Whether or not registered within a club
- • Not opposed to the research
- Exclusion Criteria:
- • Protected adults (guardianship or curatorship) or those under court protection
About Centre Hospitalier Universitaire De La Réunion
The Centre Hospitalier Universitaire de la Réunion (CHU Réunion) is a leading academic medical center located on the island of Réunion. As a prominent clinical trial sponsor, CHU Réunion is dedicated to advancing medical research and improving patient care through innovative therapeutic studies and collaborations. With a focus on multidisciplinary approaches, the institution leverages its expertise in various medical fields to address pressing health challenges, enhance clinical practices, and promote evidence-based medicine. CHU Réunion is committed to ensuring patient safety and ethical standards in all research endeavors, contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Nicolas Bouscaren, MD
Principal Investigator
CHU de la Réunion
Julien Sebon, MD
Study Chair
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported